Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$85
|
$239B |
3.7x |
8.2x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$187B |
3.0x |
7.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€86
|
$130B |
2.5x |
8.4x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£16
|
$105B |
2.5x |
7.4x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 219
|
$78.4B |
4.9x |
14.7x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€249
|
$55.6B |
6.9x |
23.3x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 55
|
$9.3B |
N/A |
N/A |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$105
|
$9.2B |
3.5x |
-6.3x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 20
|
$8.4B |
4.2x |
65.2x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 210
|
$7.2B |
7.7x |
26.4x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$26
|
$5.8B |
2.7x |
-1.5x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2741
|
$5.0B |
11.2x |
35.4x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$42
|
$3.9B |
N/A |
N/A |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.8B |
5.7x |
15.2x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 53
|
$3.7B |
11.6x |
73.2x |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 16
|
$2.8B |
6.4x |
21.1x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.7B |
29.1x |
N/A |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 238
|
$2.6B |
2.7x |
8.0x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 9161
|
$2.5B |
N/A |
N/A |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 11
|
$2.3B |
6.0x |
22.0x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 52
|
$2.2B |
10.6x |
-58.7x |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 47600
|
$2.1B |
5.6x |
-745.7x |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$102
|
$2.1B |
8102.4x |
N/A |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 11
|
$1.5B |
8.1x |
26.7x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 15279
|
$1.5B |
N/A |
N/A |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$1.4B |
8.6x |
9.4x |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 22
|
$1.3B |
7.4x |
24.9x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 75
|
$1.3B |
6.8x |
16.9x |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 7
|
$1.3B |
44.8x |
-38.3x |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€29
|
$1.2B |
N/A |
N/A |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$1.2B |
280.2x |
-4.8x |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 13
|
$1.1B |
8.2x |
13.7x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$16
|
$1.1B |
127.4x |
-5.1x |
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$58
|
$1.0B |
19.0x |
-10.2x |
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$16
|
$951M |
4.0x |
-2.5x |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$8
|
$932M |
0.9x |
2.8x |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$907M |
5.8x |
11.1x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$904M |
4.4x |
-28.2x |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 27
|
$850M |
3.6x |
11.6x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$825M |
2.5x |
54.8x |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 4
|
$811M |
4.4x |
N/A |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$5
|
$788M |
4.4x |
-13.2x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$21
|
$738M |
304.0x |
-5.2x |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$35
|
$718M |
5.9x |
-6.7x |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$663M |
8.9x |
-4.2x |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$640M |
3668.0x |
N/A |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$571M |
N/A |
N/A |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 449
|
$564M |
N/A |
N/A |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 23
|
$557M |
208.1x |
-28.4x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$523M |
6.4x |
-23.4x |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 7
|
$518M |
N/A |
-8.2x |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$2
|
$505M |
132.0x |
N/A |
I-MAB
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$503M |
N/A |
N/A |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 428
|
$462M |
2.1x |
N/A |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$451M |
727.8x |
N/A |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$405M |
N/A |
N/A |
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$377M |
3.7x |
16.7x |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 37
|
$348M |
17.6x |
-1188.1x |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$341M |
7.5x |
-4.4x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 22
|
$325M |
1.8x |
7.6x |
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$299M |
12.4x |
-0.6x |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$283M |
317490.2x |
-10.9x |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 18
|
$276M |
N/A |
N/A |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 22
|
$266M |
1.3x |
6.7x |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$212M |
20.4x |
-5.6x |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$205M |
1.2x |
N/A |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$200M |
N/A |
-4.9x |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$190M |
118623.8x |
-7.6x |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 36
|
$180M |
N/A |
N/A |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$154M |
N/A |
N/A |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 16
|
$152M |
N/A |
N/A |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$146M |
N/A |
N/A |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€6
|
$145M |
2.5x |
10.0x |
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$138M |
13.7x |
N/A |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 20
|
$132M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$131M |
34.2x |
-7.8x |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$126M |
N/A |
N/A |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 8840
|
$122M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$122M |
N/A |
N/A |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$19
|
$122M |
N/A |
N/A |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$119M |
N/A |
N/A |
TuHURA Biosciences
|
United States of America |
Vaccines & Immunotherapies
|
$2
|
$115M |
N/A |
N/A |
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$110M |
N/A |
-3.2x |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$15
|
$99.4M |
0.8x |
7.1x |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$99.2M |
N/A |
N/A |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 7
|
$95.6M |
9.7x |
N/A |
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$90.9M |
N/A |
-0.6x |
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$88.0M |
770.4x |
N/A |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$87.3M |
9.4x |
N/A |
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$17
|
$86.8M |
4094.0x |
-0.4x |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$84.2M |
N/A |
-3.7x |
Kyverna Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$81.0M |
N/A |
-0.5x |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$79.0M |
10813.2x |
-0.3x |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$76.6M |
18.6x |
N/A |
Adaptimmune Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$75.7M |
1.3x |
-1.3x |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$14
|
$67.1M |
N/A |
N/A |
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$65.1M |
21.8x |
-1.7x |
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$43.0M |
N/A |
N/A |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€5
|
$42.5M |
N/A |
N/A |
Adicet Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$42.1M |
21.1x |
N/A |